Danpure C J, Jennings P R, Penketh R J, Wise P J, Cooper P J, Rodeck C H
Division of Inherited Metabolic Diseases, Clinical Research Centre, Harrow, Middlesex, U.K.
Prenat Diagn. 1989 Apr;9(4):271-81. doi: 10.1002/pd.1970090406.
Primary hyperoxaluria type 1 (PH1) is caused by a deficiency of the hepatic peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT, EC 2.6.1.44) (Danpure and Jennings, FEBS Lett., 201, 20-24, 1986). The activity of AGT has been measured in fetal livers of gestational age 14-21 weeks. Activity increases up to 17 weeks and then levels off between 17 and 21 weeks. At this time, the mean AGT activity is about 30 per cent of the mean normal postnatal level. As in adult liver, the AGT enzyme activity and the AGT immunoreactive protein are peroxisomal. Prenatal diagnosis has been performed by measuring AGT enzyme activity and immunoreactive AGT protein on liver biopsies from two fetuses at risk for primary hyperoxaluria type 1. One was unaffected and one was affected.
1型原发性高草酸尿症(PH1)是由肝脏过氧化物酶体酶丙氨酸:乙醛酸转氨酶(AGT,EC 2.6.1.44)缺乏引起的(Danpure和Jennings,《欧洲生物化学学会联合会快报》,201,20 - 24,1986)。已在孕龄14 - 21周的胎儿肝脏中测量了AGT的活性。活性在17周前增加,然后在17至21周之间趋于平稳。此时,AGT的平均活性约为出生后正常平均水平的30%。与成人肝脏一样,AGT酶活性和AGT免疫反应蛋白位于过氧化物酶体中。通过测量来自两个有1型原发性高草酸尿症风险胎儿的肝脏活检组织中的AGT酶活性和免疫反应性AGT蛋白进行了产前诊断。一个未受影响,一个受影响。